C07C 311/15
Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of
Official title: Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
C07C311/15 (Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of) appears on 1,634 US grants and 1,487 published applications in this corpus.
Search patents in C07C- Granted patents
- 1,634
- Published applications
- 1,487
- Assignees
- 772
- Inventors
- 5,266
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 7 | 0 |
| 1977 | 12 | 0 |
| 1978 | 33 | 0 |
| 1979 | 6 | 0 |
| 1980 | 2 | 0 |
| 1981 | 4 | 0 |
| 1982 | 1 | 0 |
| 1983 | 1 | 0 |
| 1984 | 0 | 0 |
| 1985 | 3 | 0 |
| 1986 | 3 | 0 |
| 1987 | 3 | 0 |
| 1988 | 5 | 0 |
| 1989 | 7 | 0 |
| 1990 | 15 | 0 |
| 1991 | 14 | 0 |
| 1992 | 23 | 0 |
| 1993 | 24 | 0 |
| 1994 | 18 | 0 |
| 1995 | 35 | 0 |
| 1996 | 43 | 0 |
| 1997 | 59 | 0 |
| 1998 | 58 | 0 |
| 1999 | 58 | 0 |
| 2000 | 51 | 0 |
| 2001 | 75 | 14 |
| 2002 | 85 | 72 |
| 2003 | 79 | 105 |
| 2004 | 54 | 102 |
| 2005 | 42 | 87 |
| 2006 | 49 | 65 |
| 2007 | 53 | 69 |
| 2008 | 51 | 66 |
| 2009 | 32 | 71 |
| 2010 | 47 | 80 |
| 2011 | 42 | 59 |
| 2012 | 52 | 57 |
| 2013 | 39 | 48 |
| 2014 | 43 | 61 |
| 2015 | 53 | 65 |
| 2016 | 41 | 51 |
| 2017 | 58 | 54 |
| 2018 | 37 | 54 |
| 2019 | 50 | 43 |
| 2020 | 32 | 50 |
| 2021 | 31 | 44 |
| 2022 | 26 | 44 |
| 2023 | 20 | 32 |
| 2024 | 17 | 40 |
| 2025 | 21 | 31 |
| 2026 | 20 | 23 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- NAMPT modulators29 Sep 2026US 12,747,203 B2Cytokinetics, Inc.
- Compound, polymerizable composition, polymer, and polymerized film22 Sep 2026US 12,741,936 B2FUJIFILM Corporation
- Sulfone compounds and pharmaceutical compositions thereof, and their therapeutic applications11 Aug 2026US 12,703,679 B2Cura Therapeutics, LLC
- Phenyl-sulfamoyl-benzoic acid derivatives as ERAP1-modulators28 Jul 2026US 12,692,223 B2Grey Wolf Therapeutics Limited
- Compounds, compositions and polymer films19 May 2026US 12,630,502 B2FUJIFILM Corporation
- Methods of treating cancer24 Sep 2026US 2026/0285807 A1Institute for Cancer Research d/b/a The Research Institute of Fox Chase Cancer Center
- Photoswitchable compounds and affinity ligands, and their use for the optical control of affinity matrices10 Sep 2026US 2026/0265179 A1AFC Innovations GmbH
- Methods and compositions for prevention of anaphylaxis20 Aug 2026US 2026/0242369 A1Baylor College of Medicine
- Usp2 inhibitors and methods of using the same for the treatment of diseases20 Aug 2026US 2026/0242394 A1Beth Israel Deaconess Medical Center, Inc.
- Isotopologues of aminoheteroaryl kinase inhibitors and uses thereof13 Aug 2026US 2026/0234111 A1Allorion Therapeutics Inc
Most cited
By later US patents
- Prostaglandin synthase inhibitors169US 5,593,994 AThe DuPont Merck Pharmaceutical Company · 1997
- Retroviral protease inhibiting compounds159US 5,142,056 AAbbott Laboratories · 1992
- Compositions for oral delivery of active agents159US 5,650,386 AEmisphere Technologies, Inc. · 1997
- Benzamides and related inhibitors of factor Xa155US 7,285,565 B2Millennium Pharmaceuticals, Inc. · 2007
- Sulfonamide inhibitors of aspartyl protease147US 5,585,397 AVertex Pharmaceuticals Incorporated · 1996